Fjarde Ap Fonden Illumina, Inc. Transaction History

Fjarde Ap Fonden

$9.89 Billion
Q4 2024

A detailed history of Fjarde Ap Fonden transactions in Illumina, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 34,886 shares of ILMN stock, worth $3.51 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

34,886

Previous 40,286 13.4%

Holding current value

$3.51 Million

Previous $5.25 Million 11.27%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$128.99 - $155.15 $696,546 - $837,810	-5,400 Reduced 13.4%	34,886 $4.66 Million
Q3 2024 Nov 08, 2024	BUY	$105.28 - $135.9 $1.52 Million - $1.96 Million	14,400 Added 55.63%	40,286 $5.25 Million
Q1 2024 Apr 25, 2024	BUY	$127.73 - $147.2 $268,233 - $309,120	2,100 Added 8.83%	25,886 $3.56 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $398,997 - $612,879	-4,300 Reduced 15.31%	23,786 $3.31 Million
Q3 2023 Oct 23, 2023	SELL	$128.91 - $192.44 $257,820 - $384,880	-2,000 Reduced 6.65%	28,086 $3.86 Million
Q2 2023 Aug 02, 2023	SELL	$183.43 - $232.67 $330,174 - $418,806	-1,800 Reduced 5.65%	30,086 $5.64 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $387,500 - $465,100	-2,000 Reduced 5.9%	31,886 $7.42 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $617,892 - $801,042	3,300 Added 10.79%	33,886 $6.85 Million
Q2 2022 Aug 11, 2022	SELL	$181.58 - $368.0 $1.11 Million - $2.24 Million	-6,100 Reduced 16.63%	30,586 $5.64 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $1.06 Million - $1.48 Million	-3,500 Reduced 8.71%	36,686 $12.8 Million
Q4 2021 Feb 15, 2022	SELL	$347.28 - $421.83 $281,644 - $342,104	-811 Reduced 1.98%	40,186 $15.3 Million
Q3 2021 Nov 15, 2021	SELL	$405.61 - $524.84 $405,610 - $524,840	-1,000 Reduced 2.38%	40,997 $16.6 Million
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $1.38 Million - $1.78 Million	-3,700 Reduced 8.1%	41,997 $19.9 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $144,512 - $201,904	400 Added 0.88%	45,697 $17.6 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $263,430 - $333,864	-900 Reduced 1.95%	45,297 $16.8 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $671,275 - $1 Million	2,500 Added 5.72%	46,197 $14.3 Million
Q2 2020 Aug 13, 2020	BUY	$256.46 - $373.01 $566,263 - $823,606	2,208 Added 5.32%	43,697 $16.2 Million
Q1 2020 May 11, 2020	SELL	$209.2 - $335.53 $188,280 - $301,977	-900 Reduced 2.12%	41,489 $11.3 Million
Q4 2019 Feb 10, 2020	SELL	$288.29 - $335.49 $86,487 - $100,647	-300 Reduced 0.7%	42,389 $14.1 Million
Q3 2019 Oct 31, 2019	BUY	$266.84 - $378.23 $213,471 - $302,584	800 Added 1.91%	42,689 $13 Million
Q2 2019 Jul 17, 2019	SELL	$300.59 - $368.15 $420,825 - $515,409	-1,400 Reduced 3.23%	41,889 $15.4 Million
Q1 2019 Apr 29, 2019	BUY	$272.57 - $321.18 $2.43 Million - $2.86 Million	8,913 Added 25.93%	43,289 $13.4 Million
Q4 2018 Jan 31, 2019	SELL	$272.46 - $366.54 $1.2 Million - $1.61 Million	-4,400 Reduced 11.35%	34,376 $10.3 Million
Q3 2018 Nov 09, 2018	SELL	$279.04 - $367.06 $528,222 - $694,844	-1,893 Reduced 4.65%	38,776 $14.2 Million
Q2 2018 Jul 12, 2018	BUY	$228.17 - $292.07 $201,474 - $257,897	883 Added 2.22%	40,669 $11.4 Million
Q1 2018 May 07, 2018	SELL	$209.54 - $253.91 $138,715 - $168,088	-662 Reduced 1.64%	39,786 $9.41 Million
Q4 2017 Feb 12, 2018	BUY	$202.23 - $230.03 $1.31 Million - $1.49 Million	6,479 Added 19.07%	40,448 $8.84 Million
Q3 2017 Nov 07, 2017	SELL	$172.3 - $213.93 $101,312 - $125,790	-588 Reduced 1.7%	33,969 $6.77 Million
Q2 2017 Aug 08, 2017	BUY	N/A	34,557	34,557 $6 Million

Others Institutions Holding ILMN

# of Institutions

922

Shares Held

139M

Call Options Held

1.24M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $15.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account